Efficacy and toxicity of salvage weekly paclitaxel chemotherapy in non-Asian patients with advanced oesophagogastric adenocarcinoma
Objectives: Survival for oesophagogastric adenocarcinoma (OGA) patients varies globally and clinical trial results are seldom replicated in clinical practice. We sought to examine the efficacy and toxicity of salvage paclitaxel chemotherapy for patients with advanced OGA at our institution. Methods:...
Main Authors: | Noelia Tarazona, Elizabeth C. Smyth, Clare Peckit, Ian Chau, David Watkins, Sheela Rao, Naureen Starling, David Cunningham |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-03-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758834015621669 |
Similar Items
-
The evolving immunotherapeutic landscape in advanced oesophagogastric cancer
by: Michael Flynn, et al.
Published: (2018-07-01) -
Targeting Vascular Endothelial Growth Factor in Oesophagogastric Cancer: A Review of Progress to Date and Immunotherapy Combination Strategies
by: Oliver Butters, et al.
Published: (2019-07-01) -
Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study
by: Fiona Turkes, et al.
Published: (2022-03-01) -
Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions
by: Katrin Bose, et al.
Published: (2017-01-01) -
Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas
by: Schmidt, T, et al.
Published: (2021)